Table 3 |
|
|
Histopathology of malignant and benign nodules |
|
|
HP of malignant nodules (n = 147) |
Number of nodules (%) |
|
|
|
|
Adenocarcinoma |
59 (40) |
|
Squamous cell carcinoma |
40 (27) |
|
Large cell cancer |
11 (7.5) |
|
Carcinoid tumor |
11 (7.5) |
|
Non-specified NSCLC |
9 (6.1) |
|
Small cell lung cancer |
8 (5.4) |
|
Other |
9 (6.1) |
|
HP of benign nodules (n = 55) |
|
|
|
|
|
Non-specified benign |
10 (18) |
|
Fibrosis-elastosis |
9 (16) |
|
Chronic inflammation |
7 (13) |
|
Lymphoid tissue hyperplasia |
4 (7.2) |
|
Squamous metaplasia 4 |
4 (7.2) |
|
Granuloma |
3 (5.5) |
|
Atypical cytology |
3 (5.5) |
|
Tuberculosis |
3 (5.5) |
|
Rheumatoid nodules |
2 (3.6) |
|
Silicoanthracotic nodules |
2 (3.6) |
|
Cryptococcus infection |
2 (3.6) |
|
Other |
6 (11) |
|
|
|
|
HP = Histopathology |
|
|
Khalaf et al. Journal of Hematology & Oncology 2008 1:13 doi:10.1186/1756-8722-1-13 |
|
